Aqui-S 50 % Solution is a Health Canada–registered veterinary drug (DIN 02540096) held by Aqui-S New Zealand Ltd., containing Isoeugenol. Health Canada lists its status as Marketed (status date 11 Apr 2024). Nexara Health has matched 2 registrations of Isoeugenol across 1 other regulated market.
Health Canada registration
| DIN | 02540096 |
|---|---|
| Brand name | Aqui-S |
| Active ingredient | Isoeugenol |
| Strength | 50 % |
| Dosage form | Solution |
| Route | Topical |
| Company | Aqui-S New Zealand Ltd. |
| Status | Marketed — 11 Apr 2024 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Isoeugenol registered in other markets
2 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Iceland | AQUI-S vet. | Scan Aqua AS | 540 g/líter | baðþ | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | AQUI-S vet. | Scan Aqua AS | 540 g/líter | baðþ | 0 | Lyfjastofnun lyfjaverdskra |
See every manufacturer of Isoeugenol worldwide →
Regulator price references for Isoeugenol
Published list or reimbursement prices for Isoeugenol presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | AQUI-S vet. | 540000mg/1000ml | glas | 65,858.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | AQUI-S vet. | 540000mg/1000ml | glas | 259,597.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Aqui-S (DIN 02540096) marketed in Canada?
Yes. Health Canada lists DIN 02540096 as Marketed as of 11 Apr 2024.
Who holds the Canadian licence for this product?
Aqui-S New Zealand Ltd. is the company of record in the Health Canada Drug Product Database.
Is Isoeugenol registered outside Canada?
Yes — Nexara Health has matched 2 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02540096, status date 2024-04-11; national medicine registries: Lyfjastofnun lyfjaverdskra; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02540096, status date 2024-04-11; national medicine registries: Lyfjastofnun lyfjaverdskra; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02540096, status date 2024-04-11; national medicine registries: Lyfjastofnun lyfjaverdskra; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.